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Abstract
Background: Diabetes is an important contributor to global morbidity and mortality. The contributions of
population aging and macroeconomic changes to the growth in diabetes prevalence over the past 20 years are
unclear.
Methods: We used cross-sectional data on age- and sex-specific counts of people with diabetes by country,
national population estimates, and country-specific macroeconomic variables for the years 1990, 2000, and 2008.
Decomposition analysis was performed to quantify the contribution of population aging to the change in global
diabetes prevalence between 1990 and 2008. Next, age-standardization was used to estimate the contribution of
age composition to differences in diabetes prevalence between high-income (HIC) and low-to-middle-income
countries (LMICs). Finally, we used non-parametric correlation and multivariate first-difference regression estimates
to examine the relationship between macroeconomic changes and the change in diabetes prevalence between
1990 and 2008.
Results: Globally, diabetes prevalence grew by two percentage points between 1990 (7.4 %) and 2008 (9.4 %).
Population aging was responsible for 19 % of the growth, with 81 % attributable to increases in the age-specific
prevalences. In both LMICs and HICs, about half the growth in age-specific prevalences was from increasing levels
of diabetes between ages 45–65 (51 % in HICs and 46 % in LMICs). After age-standardization, the difference in the
prevalence of diabetes between LMICs and HICs was larger (1.9 % point difference in 1990; 1.5 % point difference
in 2008). We found no evidence that macroeconomic changes were associated with the growth in diabetes
prevalence.
Conclusions: Population aging explains a minority of the recent growth in global diabetes prevalence. The increase
in global diabetes between 1990 and 2008 was primarily due to an increase in the prevalence of diabetes at ages
45–65. We do not find evidence that basic indicators of economic growth, development, globalization, or
urbanization were related to rising levels of diabetes between 1990 and 2008.
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Introduction
Diabetes is a rapidly growing contributor to global mor-
bidity and mortality. Studies estimate that 194 million
people developed diabetes between 1980 and 2008 and
an additional 150–200 million people will develop
diabetes by the year 2030 [1–5]. Although diabetes has
historically had a higher burden in high-income countries
(HICs), the prevalence of diabetes has been rising rapidly
in low-to-middle-income countries (LMICs), where 80 %
of people with diabetes live [6].
Diabetes prevalence can increase in two ways: (1) as
populations age, the incidence and prevalence of dia-
betes can increase simply due to more people living to
older ages, where the risk of diabetes is generally higher
compared to younger ages; and (2) the prevalence of dia-
betes can increase if the age-specific incidence increases
over time [7]. Although population aging is recognized
as an important cause of increasing diabetes prevalence,
the share of diabetes growth over the past 20 years
attributable to population aging is unknown [4, 8].
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Furthermore, it is unknown how much of the difference
in diabetes prevalence across national income groups is
due to the older age distribution of HICs compared to
LMICs [9].
The contribution of macroeconomic changes to rising
levels of diabetes is also unclear—while studies have the-
oretically linked urbanization and globalization to rising
prevalence of non-communicable disease, little empirical
evidence exists confirming these relationships [10–12].
Studies of economic growth and life expectancy have
found that for some countries increases in life expect-
ancy are correlated with economic growth [13–16],
while for others, life expectancy has increased in the ab-
sence of economic growth [17, 18]. However, these types
of analyses have not been extended to diabetes.
The primary aims of this paper are: (1) to determine
the contribution of population aging to the growth in
diabetes prevalence between 1990 and 2008; (2) to deter-
mine the contribution of age composition to differences
in diabetes prevalence between HIC and LMICs; and (3)
to identify macroeconomic changes that were associated
with the growth in diabetes prevalence.
Methods
We used published cross-sectional data on age and sex-
specific counts of people with diabetes by country,
national population counts, and country-specific macro-
economic variables for the years 1990, 2000, and 2008.
Diabetes and population sizes
Counts of the number of people aged 20–100 with dia-
betes by 10-year age and sex groups for 193 countries in
1990 and 2008 were obtained from recent data published
by Danaei and colleagues [1]. These data combine indi-
viduals with both type 1 and type 2 diabetes. To estimate
counts of people with diabetes by year-country-sex-age
groups, Danaei and colleagues collected national data on
multiple glycemic metrics (including but not limited to
hemoglobinA1c, mean postprandial glucose, and fasting
plasma glucose) from a combination of health examin-
ation surveys and epidemiological studies. Regression
models were used to standardize and express all gly-
cemic data in terms of fasting plasma glucose (FPG).
Diabetes prevalence was then estimated for each year-
country-sex-age group using the American Diabetes
Association classification of diabetes (FPG of 7 mmol/L
or greater). This prevalence was then applied to the
population size for each group to calculate the number
of people with diabetes. Where there were missing data,
Danaei and colleagues used a Bayesian Hierarchical
model to predict counts of people with diabetes (the
predictive model had strong predictive validity: the
95 % uncertainty intervals for predicted FPG included
95–98 % of the actual values). Additional steps were
taken to capture uncertainty and rural-urban differences
in diabetes prevalence. Further details of the methodology
were presented in Danaei and colleagues [1].
Age-sex-specific population estimates were collected
from the United Nations World Population Prospects
2010 report for the years 1990–2008. Counts of popula-
tion in these data were extracted from a combination of
national censuses, official government estimates, and
surveys. The United Nations Department of Economic
and Social Affairs, Population Division corrected the
data for misreporting, missing data, and other error [9].
We define diabetes prevalence as the share of individ-
uals living with diabetes; we estimate diabetes prevalence
by dividing the number of individuals with diabetes in a
population by the total size of that population.
Macroeconomic measures
Despite limited research on the relationship between
diabetes prevalence and macroeconomic variables, the
literature on the relationship between mortality and
macroeconomic changes is rich. Drawing from the lit-
erature on the relationship between mortality and
macroeconomic changes, we identified the following var-
iables as potential correlates of diabetes prevalence:
gross domestic product (GDP) per capita, foreign direct
investment net inflows, percent of the population resid-
ing in urban areas, female labor force participation, and
health expenditure per capita.
Estimates of GDP per capita, foreign direct investment
net inflows, percent of the population residing in urban
areas, female labor force participation, and health ex-
penditure per capita for 159 countries were extracted
from the World Bank World Development Indicator
database for the years 2000 and 2008 [19]. Data for 1990
were not used since many of the countries were missing
macroeconomic information for that year. Gross domes-
tic product per capita, health expenditure per capita,
and foreign direct investment were all standardized by
purchasing power parity. For more information, see
World Bank World Development Indicators, [19]. We
dropped the United Arab Emirates, St. Lucia, Equatorial
Guinea, and Maldives due to implausible values. Using
the World Bank cutoff for national income, countries
with a 2012 gross national income per capita of $12,616
or more were classified as high-income countries, while
countries that did not meet this level were classified as
low-to-middle-income countries.
Statistical analysis
We began by quantifying the contribution of population
aging to the growth in diabetes prevalence between 1990
and 2008 using decomposition approaches [20] Additional
file 1. The decomposition identifies how much of the growth
in diabetes prevalence can be attributed to populations
Sudharsanan et al. Population Health Metrics  (2015) 13:33 Page 2 of 7
getting older and how much is due to changes in the age-
specific prevalence. The share of diabetes growth attributable
to changes in the age-specific prevalence was further decom-
posed to identify the percent contribution of each age group.
We first decomposed the change in diabetes prevalence for
the global population, then for HICs and LMICs separately.
We next examined the role of age-compositional differ-
ences to differences in diabetes prevalence between HICs
and LMICs. Within each year (1990 and 2008), we com-
bined age-specific prevalence estimates from LMICs with
the age composition of HICs. This approach allowed us to
standardize the age distributions of the two national in-
come groups providing an estimate of what the prevalence
of diabetes in LMICs would be if they had the age distri-
bution of HICs.
We next estimated the relationship between diabetes
prevalence and macroeconomic indicators using bivari-
ate correlations and multivariate ordinary least squares
(OLS) regression. Compared to decomposition, these
approaches are better suited for estimating multivariate
relationships over multiple time points, making these
methods relevant for our analysis using many macroeco-
nomic variables measured over time.
Because differences in the age composition of coun-
tries could affect our estimates, we began by age-sex
standardizing diabetes prevalence to the 2000 world
population. We then took the first difference value of all
variables by subtracting a country’s responses on each
variable in 2008 by their response on that same variable
in 2000. Our primary outcome was the change in dia-
betes prevalence between 2000 and 2008. By modeling
the change in diabetes prevalence on the change in the
macroeconomic variables, we eliminate the effect of
time-invariant differences between countries that may be
related to both diabetes prevalence and the macroeco-
nomic variables.
The bivariate relationship between the change in dia-
betes prevalence and the change in each of the macro-
economic variables was estimated using the Kendall Tau
rank correlation coefficient. We plotted the LOWESS
estimation curve, which estimates the shape of the bi-
variate correlations. Finally, we used a multivariate
OLS regression to estimate the relationship between
diabetes prevalence and all the macroeconomic variables
simultaneously.
Results
Globally, diabetes prevalence grew by two percentage
points between 1990 (7.4 %) and 2008 (9.4 %) (Table 1).
This suggests that roughly 150 million more individuals
are living with diabetes. This growth was not unique to
HICs or LMICs: the prevalence of diabetes in HICs grew
from 7.1 to 9.8 %, with a similar level of growth for
LMICs (7.5–9.3 %).
Between 1990 and 2008 the prevalence of diabetes in-
creased for both men and women. However, the sex pat-
tern in the level of diabetes differed between HICs and
LMICs. In HICs, men had higher levels of diabetes
prevalence compared to women for both years (7.4 %
versus 6.8 % in 1990; 11 % versus 8.6 % in 2008); in con-
trast, women had higher levels of diabetes prevalence in
LMICs (7.6 % versus 7.4 % in 1990; 9.4 % versus 9.1 % in
2008). Furthermore, although the growth in diabetes
prevalence over time was similar for most of the
income-sex groups, diabetes prevalence grew substan-
tially more for men in HICs (3.6 percentage point
growth compared to 1.7–2.0 percentage points for the
other groups).
Overall, population aging was responsible for 19.2 % of
the growth in diabetes prevalence, with 80.8 % of the
growth attributable to increases in the age-specific
prevalence (Table 1). Population aging was slightly more
important in HICs compared to LMICs (28.2 % versus
20.7 %). The contribution of population aging also
remained relatively consistent by sex. Women in HICs
are the main exception to this pattern, as population
aging was responsible for a much larger share of their
growth in diabetes prevalence compared to the other
groups (37.2 % compared to 18.0–24.3 % for the other
groups).
Figure 1 presents the contribution of each age group
to the share of diabetes growth attributable to changes
in the age-specific prevalence. In both LMICs and HICs
the growth in diabetes between 1990 and 2008 was pri-
marily due to an increase in the prevalence of diabetes
between ages 45 and 65. Globally, 24.5 % of the share of
diabetes prevalence attributable to changes in the age-
specific prevalence was between ages 45 and 55, and
22.4 % between ages 55 and 65. This pattern was similar
for LMICs with 24.9 % between ages 45 and 55. In
contrast to LMICs, the older middle ages had a larger
impact on diabetes growth in HICs (27.7 % attributable
to ages 55–65). Importantly, changes in the age-specific
prevalence of diabetes at older ages only had a minor
impact on the growth in diabetes prevalence between
1990 and 2008 for both LMICs and HICs.
Despite having very different age compositions, HICs
and LMICs had fairly similar levels of diabetes preva-
lence in 1990 and 2008. We observed a small crossover
in the prevalence of diabetes between 1990 and 2008: in
1990, LMICs had a slightly higher prevalence of diabetes
(7.5 % versus 7.1 %) but by 2008 the prevalence of dia-
betes was higher in HICs (9.8 % versus 9.3 %). When we
estimated what the prevalence of diabetes in LMICs
would be if they had the age distribution of HICs
(Table 2), we found that LMICs had a higher prevalence
of diabetes in both 1990 (9.0 % versus 7.1 %) and 2008
(11.3 % versus 9.8 %).
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Figure 2 presents the results of the bivariate analysis.
For each scatterplot, we present the correlation coeffi-
cient and the corresponding p-value. We did not find
evidence that any of the variables were associated with
change in diabetes prevalence. Since many of these vari-
ables are likely to be correlated with each other, a multi-
variate model is needed to identify the independent
relationship of each variable with the change in diabetes
prevalence.
We used a multivariate model to test whether all the
macroeconomic variables considered simultaneously
were associated with the change in diabetes prevalence,
but did not find any independent associations (Table 3).
Even when considered jointly, we found no evidence that
the macroeconomic variables were associated with the
change in diabetes prevalence (F-test p = 0.450).
Discussion
We find that population aging was not the primary
cause of increasing global diabetes prevalence over this
period. Even when looking at countries by national in-
come, the clear trend is that diabetes prevalence in-
creased as a result of growing age-specific levels of
diabetes, specifically at ages 45–65.
Fig. 1 The contribution of each age group to the growth in diabetes prevalence attributable to increasing age-specific prevalences, 1990–2008,
193 countries, adults ages 25 to 100
Table 1 Growth in diabetes between 1990 and 2008 attributable to age compositional changes and age-specific prevalence
changes, 193 countries, adults ages 25 to 100
Region 1990 prevalence 2008 prevalence Growth % change due to age composition % change due to age- specific prevalence
Both sexes
World 7.4 % 9.3 % 1.9 % 19.2 % 80.8 %
HICs 7.1 % 9.8 % 2.7 % 28.2 % 71.8 %
LMICs 7.5 % 9.2 % 1.7 % 20.7 % 79.3 %
Males
World 7.4 % 9.4 % 2.0 % 20.3 % 79.7 %
HICs 7.4 % 11.0 % 3.6 % 24.3 % 75.7 %
LMICs 7.4 % 9.1 % 1.7 % 22.1 % 77.9 %
Females
World 7.4 % 9.2 % 1.8 % 18.0 % 82.0 %
HICs 6.8 % 8.6 % 1.8 % 37.2 % 62.8 %
LMICs 7.6 % 9.4 % 1.8 % 19.1 % 80.1 %
Notes: Crude prevalence shown. Countries were classified as high income based on World Bank designations. Estimates for percentage change were taken from a
decomposition analysis of the 1990 and 2008 data
Data source: Danaei and colleagues, [1]
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Although the prevalence of diabetes looks comparable
between HICs and LMICs, differences in demographic
composition obscured the underlying levels of diabetes.
If LMICs had the age distribution of HICs, the preva-
lence of diabetes would be 1.5–2.0 percentage points
higher in both 1990 and 2008. Given that the percent of
the global population above the age of 60 is expected to
grow from 10 % in 2000 to 32.2 % in 2100, these results
suggest that even if current levels of age-specific diabetes
remain constant, the prevalence of diabetes in both HICs
and LMICs will increase considerably as their popula-
tions age [21].
Consistent with many prior studies, we find that the
global prevalence of diabetes increased between 1990
and 2008. However, there were important differences in
growth by sex and national income. Men in HICs had
consistently higher levels of diabetes compared to
women—they also experienced the largest growth in dia-
betes between 1990 and 2008. In contrast, women had
higher levels of diabetes in LMICs.
A large body of work has linked macroeconomic con-
ditions with population health. Using country-specific
measurements of GDP per capita to measure economic
growth, female labor force participation, and health ex-
penditure per capita as indicators of development, for-
eign direct investment as an indicator of globalization,
and the percent of the population living in urban areas
to measure urbanization, we fail to find an association
between any of the commonly used macroeconomic
measures and diabetes prevalence. Diabetes prevalence
may be growing due to rising obesity and shifting dietary
patterns that are unrelated to economic growth and de-
velopment. For example, data from 1962 to 1994 show a
weakening relationship between economic growth and
Table 2 Crude and standardized estimates of diabetes
prevalence for HICs and LMICs, 193 countries, 1990 and 2008
1990 2008
Actual
HICs 7.1 % 9.8 %
LMICs 7.5 % 9.3 %
Difference 0.4 % −0.5 %
Standardized
HICs 7.1 % 9.8 %
LMICs 9.0 % 11.3 %
Difference 1.9 % 1.5 %
Notes: For the standardized estimates, LMICs were standardized to the age
distribution of HICs for that year
Data source: Danaei and colleagues, [1]
Fig. 2 First-difference Kendall Correlation of age-gender-standardized diabetes prevalence and macroeconomic correlates with estimated LOWESS
line, 2000–2008, 155 countries. Each point represents one country. τ is the Kendall correlation coefficient; p-values shown test whether τ is statistically
different from 0
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fat consumption, potentially because the cost of cheap
fats has lowered in countries at all levels of national in-
come [22]. Furthermore, increased economic growth is
only empirically associated with increased food con-
sumption at very low levels of GDP, with a pronounced
flattening of the relationship at moderate to high levels
of income. The composition of food consumption shifts
from carbohydrates to fats at higher levels of GDP per
capita but this relationship also plateaus, with many not-
able outliers including Japan [23].
Food cultures may also modify the effect of economic
growth on diet and diabetes outcomes [24]. For example,
South Korea has retained a largely traditional diet des-
pite rapid economic growth, and has one of the lowest
obesity rates in Asia [25]. Further studies elucidating
how shifting macroeconomic conditions influence be-
havioral factors are warranted.
To our knowledge this analysis is one of the first to
empirically test the associations between macroeco-
nomic changes and global diabetes prevalence. We were
also able to refine estimates of the contribution of popu-
lation aging by using rich retrospective data, rather than
hypothetical projected data that previous studies have
relied on. By using longitudinal data with first differ-
ences, our analysis controlled for time-invariant differ-
ences between countries—providing a robust evaluation
of the association between macroeconomic changes and
diabetes prevalence.
There are some limitations to our approach. We mea-
sured the effect of population aging using 10-year age
groups (with the exception of the final age group). For
our method of decomposition, 5-year age intervals
would have provided a more accurate decomposition
result. For groups with missing data, Danaei and col-
leagues estimated counts of individuals with diabetes
based on patterns of diabetes in similar contexts. If the
true levels of diabetes in these groups were different
from the imputed counts, our estimates of the contribu-
tion of population aging and changes in the age-specific
levels of diabetes prevalence would be biased. Without
knowing the direction of bias for the imputed values,
the direction of the bias for our estimates is unclear.
Our models do not incorporate Danaei and colleagues’
measures of uncertainty; while incorporating the uncer-
tainty in the predicted counts of individuals with dia-
betes would provide variance estimates for our main
results, it would not change our point estimates of the
contributions of population aging and changes in the
age-specific levels of diabetes prevalence. Still, since we
do not have variance estimates for the estimated contribu-
tions, small differences across groups of countries should
be interpreted cautiously. Importantly, our macroeco-
nomic indicators are aggregated at the population level
and may not capture the complex dimensions of these
macroeconomic processes. For example, a single indicator
of foreign direct investment is unlikely to capture all as-
pects of globalization. Other measures of globalization,
such as indices of market deregulation, may result in dif-
ferent conclusions [26]. Using individual level data would
also provide better insight into the relationship between
economic changes and diabetes. We also measured
macroeconomic changes over a relatively short time
period, 8 years; extending this time range in future work
may provide important information on long-run health
and economic trends. Finally, the use of partially imputed
data could affect the relationship between the macroeco-
nomic variables and diabetes prevalence in two ways. First,
the use of imputed data may have affected our coefficient
estimates. Since the imputed data are based on prediction
models, our estimates of the coefficients may be biased
downward if the imputation process for missing groups
introduced measurement error into the predicted counts
of individuals with diabetes. The coefficients may also be
biased if the predicted counts of individuals with diabetes
for missing groups are biased. Second, since our regres-
sion estimates do not account for the imputation uncer-
tainty, the standard errors for the coefficients on the
macroeconomic variables are underestimated. However,
Table 3 Estimated multivariate associations between the change in macroeconomic variables and change in age-sex-standardized
diabetes prevalence between 2000 and 2008 (N = 155)
Estimated coefficient Lower 95 % CI Upper 95 % CI
GDP per capita (*1000) −0.000742 −0.001682 0.000198
Foreign direct investment (*1000) 0.165000 −0.148000 0.445000
Female labor force participation 0.000163 −0.000306 0.000632
Health expenditure per capita (*1000) 0.001208 −0.003148 0.005564
Percent of the population residing in urban areas −0.000742 −0.000946 0.000459
F-test p-value = 0.450
Notes: Coefficients on GDP per capita, foreign direct investment, and health expenditure per capita represent the change in diabetes prevalence associated with a
$1000 increase. Coefficients for female labor force participation and percent of the population residing in urban areas represent the change in diabetes
prevalence associated with a 1-percentage point increase
Data source: Danaei and colleagues, [1]; World Bank World Development Indicators, [19]
* p <0.05, ** p <0.01, *** p <0.001
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given that we do not observe statistically significant rela-
tionships, correcting the standard errors to account for
imputation uncertainty would not change the significance
on any of the coefficients. Further research in this area
would benefit from raw diabetes data to determine the ex-
tent of the relationship between macroeconomic changes
and changes in diabetes prevalence.
Conclusion
We find that the growth in global diabetes prevalence
was not an inevitable side effect of populations growing
older. Between 1990 and 2008, the increase in the global
prevalence of diabetes was primarily due to an increase
in the prevalence of diabetes at ages 45–65. This implies
that even if current levels of diabetes across age groups
remain constant, the prevalence of diabetes in both HICs
and LMICs will continue to rise as their populations
continue to age. Diabetes prevalence also appears to be
unrelated to multiple indicators of economic growth and
appears to be increasing in countries at all levels of na-
tional income.
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